Order Article Reprints

Bradáčová P, Slavík L, Úlehlová J, Kriegová E, Jará E, Bultasová L, Friedecký D, Ullrychová J, Procházková J, Hluší A, et al. Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients. Biomedicines. 2023; 11(12):3329. https://doi.org/10.3390/biomedicines11123329

Bradáčová, Pavla, Luděk Slavík, Jana Úlehlová, Eva Kriegová, Eliška Jará, Lenka Bultasová, David Friedecký, Jana Ullrychová, Jana Procházková, Antonín Hluší, and et al. 2023. "Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients" Biomedicines 11, no. 12: 3329. https://doi.org/10.3390/biomedicines11123329

Bradáčová, P., Slavík, L., Úlehlová, J., Kriegová, E., Jará, E., Bultasová, L., Friedecký, D., Ullrychová, J., Procházková, J., Hluší, A., Manukyan, G., & Štefaničková, L. (2023). Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients. Biomedicines, 11(12), 3329. https://doi.org/10.3390/biomedicines11123329